Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT

NARecruitingINTERVENTIONAL
Enrollment

266

Participants

Timeline

Start Date

March 21, 2024

Primary Completion Date

March 30, 2026

Study Completion Date

June 30, 2026

Conditions
MoxibustionHematopoietic Stem Cell TransplantationHemorrhagic CystitisPrevention
Interventions
OTHER

Moxibustion

The experimental group received moxibustion of Zhongji, Guanyuan, and Qihai for 30 min qd starting on the first day after HSCT was performed until the 14th day after transplantation, while treated conventionally.

OTHER

Symptomatic treatment

The control group received conventional symptomatic treatment.

Trial Locations (4)

311121

NOT_YET_RECRUITING

Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Hangzhou

430000

RECRUITING

Yi Zhang, Wuhan

450002

RECRUITING

Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Zhengzhou

650032

RECRUITING

Hematology Department, The First People's Hospital of Yunnan, Kunming

All Listed Sponsors
collaborator

The First People's Hospital of Yunnan

OTHER

collaborator

The First Affiliated Hospital of Zhengzhou University

OTHER

collaborator

First Affiliated Hospital of Zhejiang University

OTHER

lead

Yi Zhang

OTHER